David is perhaps best known for his work at Kite Pharma, where he was the head of R&D and chief medical officer who oversaw the team that developed one of the first two chimeric antigen receptor-modified T-cell therapies (CAR-T) for cancer. That personalized cancer immunotherapy, Yescarta, ...
Stephen Hahn touted the box’s features and benefits – a 6.6-pound box, the size of a toaster, that could deliver accurate yes-no test results in 15 minutes— at a Rose Garden news conference back in March. President Trump even seemed to cradle it briefly. In late March, when horrific...
Warts are tricky little devils, they are a barrier that keeps the virus that causes them safe and undetected by your immune system-hence why they last so long. It is our job then to alert our body to this invader, and you can do so by using a sterile needle (this is known as immu...
More recently, liposomal irinotecan-FU combination, doc- etaxel [76], as well as immunotherapy have also been studied [53, 77]. Patients with sensitive platinum disease (progres- sion 3–6 months after the end of first-line treatment) may benefit from re-treatment. Doublet regimen of ...
The surface expression of PSMA makes it an ideal target for both imaging and possible therapy or even immunotherapy. Antibody-drug conjugates, radioligands, bispecific T-cell engagers, and CAR T-cells are being investigated (14Marshall C.H. Antonarakis E.S. Emerging treatments for metastatic ...